TWI256951B - Thiazolyl amide derivatives - Google Patents
Thiazolyl amide derivativesInfo
- Publication number
- TWI256951B TWI256951B TW089127599A TW89127599A TWI256951B TW I256951 B TWI256951 B TW I256951B TW 089127599 A TW089127599 A TW 089127599A TW 89127599 A TW89127599 A TW 89127599A TW I256951 B TWI256951 B TW I256951B
- Authority
- TW
- Taiwan
- Prior art keywords
- amide derivatives
- thiazolyl amide
- thiazolyl
- medicaments
- derivatives
- Prior art date
Links
- -1 Thiazolyl amide Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19962532A DE19962532A1 (de) | 1999-12-23 | 1999-12-23 | Thiazolylamid-Derivate |
| DE10039265A DE10039265A1 (de) | 2000-08-11 | 2000-08-11 | Thiazolylamid-Derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TWI256951B true TWI256951B (en) | 2006-06-21 |
Family
ID=26006669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW089127599A TWI256951B (en) | 1999-12-23 | 2000-12-22 | Thiazolyl amide derivatives |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7105553B2 (es) |
| EP (1) | EP1244641B1 (es) |
| JP (1) | JP4726175B2 (es) |
| KR (1) | KR100768361B1 (es) |
| CN (1) | CN1235890C (es) |
| AR (1) | AR029210A1 (es) |
| AT (1) | ATE293104T1 (es) |
| AU (1) | AU784286B2 (es) |
| BR (1) | BR0017030B8 (es) |
| CA (1) | CA2396720C (es) |
| CO (1) | CO5261491A1 (es) |
| DE (1) | DE50010060D1 (es) |
| DK (1) | DK1244641T3 (es) |
| DO (1) | DOP2000000109A (es) |
| ES (1) | ES2240233T3 (es) |
| IL (2) | IL149897A0 (es) |
| MX (1) | MXPA02006243A (es) |
| MY (1) | MY134880A (es) |
| NZ (1) | NZ519701A (es) |
| PE (1) | PE20010964A1 (es) |
| PL (1) | PL208707B1 (es) |
| PT (1) | PT1244641E (es) |
| SV (1) | SV2002000249A (es) |
| TW (1) | TWI256951B (es) |
| UY (1) | UY26495A1 (es) |
| WO (1) | WO2001047904A1 (es) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2000259734A1 (en) * | 2000-06-15 | 2001-12-24 | Gerald Kleymann | Method for identifying compounds with anti-herpes activity |
| DE10129714A1 (de) * | 2001-06-22 | 2003-01-02 | Bayer Ag | Topische Anwendung von Thiazolylamiden |
| DE10131128A1 (de) * | 2001-06-28 | 2003-01-16 | Bayer Ag | Sekundäre Sulfonamide |
| AR036873A1 (es) | 2001-09-07 | 2004-10-13 | Euro Celtique Sa | Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento |
| AR037233A1 (es) * | 2001-09-07 | 2004-11-03 | Euro Celtique Sa | Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento |
| DK2578229T3 (da) * | 2004-09-09 | 2013-10-07 | Novartis Vaccines & Diagnostic | Faldende potentielle iatrogene risici associeret med vaccine-antigener |
| DE102005014248A1 (de) | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid |
| MX2007015216A (es) * | 2005-06-03 | 2008-02-22 | Xenon Pharmaceuticals Inc | Derivados de aminotiazol y sus usos como agentes terapeuticos. |
| US20070032488A1 (en) * | 2005-08-05 | 2007-02-08 | Genelabs Technologies, Inc. | 6-Membered aryl and heteroaryl derivatives for treating viruses |
| AU2006295260A1 (en) * | 2005-08-29 | 2007-04-05 | Gerard M. Housey | Theramutein modulators |
| SI2586434T1 (sl) * | 2006-03-17 | 2016-09-30 | The Johns Hopkins University | Derivati n-hidroksilsulfonamida kot novi fiziološko uporabni donorji nitroksila |
| WO2008140583A2 (en) * | 2006-11-22 | 2008-11-20 | The Regents Of The University Of California | Functionalized boron nitride nanotubes |
| EP2573086A1 (en) * | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
| EP2573085A1 (en) | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(aminosulfonyl)-4methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl] acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range |
| AU2014217962A1 (en) * | 2013-02-12 | 2015-09-17 | Aicuris Gmbh & Co. Kg | Helicase-primase inhibitors for use in a method of treating Alzheimer's Disease |
| CA2954526C (en) * | 2014-07-07 | 2023-03-07 | Prophylaxis, Llc | Viral prophylaxis treatment methods and pre-exposure prophylaxis kits |
| MX375099B (es) * | 2016-04-06 | 2025-03-06 | Innovative Molecules Gmbh | Derivados de aminotiazol útiles como agentes antivíricos. |
| ES2941390T3 (es) * | 2016-11-28 | 2023-05-22 | Aicuris Gmbh & Co Kg | Hemihidrato de la base libre de la N-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-N-metil-2-[4-(2-piridinil)fenil]acetamida, métodos de fabricación y sus usos |
| CN117186084A (zh) | 2016-11-28 | 2023-12-08 | 艾库里斯有限及两合公司 | 普瑞利韦磺酸盐、其药物制剂、制造方法及治疗疱疹病毒的用途 |
| AR110250A1 (es) | 2016-11-28 | 2019-03-13 | Aicuris Anti Infective Cures Gmbh | Formulación tópica que comprende n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida |
| JP7150343B2 (ja) * | 2017-01-09 | 2022-10-11 | フェーノ・セラピューティクス・カンパニー・リミテッド | チアゾール誘導体およびその使用 |
| WO2019068817A1 (en) * | 2017-10-05 | 2019-04-11 | Innovative Molecules Gmbh | SUBSTITUTED THIAZOLEAN ENANTIOMERS AS ANTIVIRAL COMPOUNDS |
| CN112384512B (zh) * | 2018-07-06 | 2022-03-29 | 辉诺生物医药科技（杭州）有限公司 | 噻唑类化合物的晶型及其应用 |
| EP3925595A1 (en) | 2020-06-17 | 2021-12-22 | AiCuris GmbH & Co. KG | Ophthalmic formulation comprising n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl] acetamide hemihydrate |
| EP4096632A1 (en) | 2020-03-26 | 2022-12-07 | AiCuris GmbH & Co. KG | Ophthalmic formulation comprising n-[5-(aminosulfonyl)-4-methyl-1,3- thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide hemihydrate |
| CN116783171A (zh) * | 2020-10-29 | 2023-09-19 | 创新分子股份有限公司 | 作为抗病毒化合物的氘化氨基噻唑化合物 |
| CA3246779A1 (en) | 2022-01-17 | 2023-07-20 | Innovative Molecules Gmbh | SOLID CRYSTALLINE FORMS OF HELICASE-PRIMASE INHIBITORS AND THEIR PREPARATION METHOD |
| CA3255969A1 (en) | 2022-05-20 | 2023-11-23 | Gilead Sciences, Inc. | Indolinyl Antiviral Compounds and Their Uses |
| CN119816497A (zh) | 2022-08-29 | 2025-04-11 | 组装生物科学股份有限公司 | 普瑞利韦的新的结晶形式 |
| EP4581031A1 (en) | 2022-08-29 | 2025-07-09 | Assembly Biosciences, Inc. | A novel crystalline form of pritelivir |
| IL319024A (en) | 2022-08-29 | 2025-04-01 | Assembly Biosciences Inc | Pharmaceutical preparations for the herpes virus |
| CR20250099A (es) | 2022-08-29 | 2025-07-29 | Assembly Biosciences Inc | Compuestos cíclicos de urea tiazolilo para el tratamiento del hsv |
| AU2024263350A1 (en) | 2023-04-26 | 2025-11-06 | Assembly Biosciences, Inc. | Oral pharmaceutical compositions |
| WO2025046456A1 (en) | 2023-08-28 | 2025-03-06 | Assembly Biosciences, Inc. | A crystalline form of 2-(3-(2,,5'-difluoro-[1,1'-biphenyl]-4-yl)-2-oxotetrahydropyrimidin-1(2h)-yl)-4-methylthiazole-5-sulfonamide |
| WO2025046457A1 (en) | 2023-08-28 | 2025-03-06 | Assembly Biosciences, Inc. | A crystalline form of 2-(3-(2,,5'-difluoro-[1,1'-biphenyl]-4-yl)-2-oxotetrahydropyrimidin-1(2h)-yl)-4-methylthiazole-5-sulfonamide |
| WO2025111598A1 (en) | 2023-11-22 | 2025-05-30 | Assembly Biosciences, Inc. | Azetidine compounds for treatment of hsv |
| WO2025172927A1 (en) | 2024-02-16 | 2025-08-21 | Assembly Biosciences, Inc. | Pharmaceutical compositions for herpes virus |
| WO2026015761A1 (en) | 2024-07-12 | 2026-01-15 | Assembly Biosciences, Inc. | Cyclic urea thiazolyl compound for treatment of viral infections unresponsive to treatment with a first antiviral therapy |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3658830A (en) | 1970-01-16 | 1972-04-25 | Shell Oil Co | 5-(substituted mercapto sulfiny sulfonyl or sulfamoyl) |
| NL7100497A (es) | 1970-01-16 | 1971-07-20 | ||
| US3847588A (en) | 1970-04-20 | 1974-11-12 | Shell Oil Co | Thiazoles herbicidal |
| US3717651A (en) | 1970-04-20 | 1973-02-20 | Shell Oil Co | Thiazoles |
| DE69624728T2 (de) | 1995-12-29 | 2003-07-10 | Boehringer Ingelheim (Canada) Ltd., Laval | Phenyl thiazol derivate mit antiherpesvirus eigenschaften |
| GB2311069A (en) | 1996-03-14 | 1997-09-17 | Merck & Co Inc | Primase isolated from human cytomegalovirus (HCMV) |
| US5705344A (en) | 1996-03-14 | 1998-01-06 | Tularik, Inc. | High-throughput screening assay for inhibitors of nucleic acid helicases |
| GB2311068A (en) | 1996-03-14 | 1997-09-17 | Merck & Co Inc | Helicase isolated from human cytomegalovirus (HCMV) |
| CA2223032A1 (en) | 1997-02-21 | 1998-08-21 | Smithkline Beecham Corporation | Use of hsv-1 ul-15 and vp5 in identifying anti-viral agents |
| DE19802437A1 (de) | 1998-01-23 | 1999-07-29 | Bayer Ag | Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe |
| AU3289299A (en) | 1998-02-19 | 1999-09-06 | Tularik Inc. | Antiviral agents |
| ES2189404T3 (es) | 1998-03-19 | 2003-07-01 | Upjohn Co | 1,3,4-tiadiazoles utiles para el tratamiento de infecciones por cmv. |
| CA2366607A1 (en) | 1999-03-08 | 2000-09-14 | Bayer Aktiengesellschaft | Thiazolyl urea derivatives and their utilization as antiviral agents |
-
2000
- 2000-12-05 DO DO2000000109A patent/DOP2000000109A/es unknown
- 2000-12-12 US US10/168,197 patent/US7105553B2/en not_active Expired - Lifetime
- 2000-12-12 JP JP2001549375A patent/JP4726175B2/ja not_active Expired - Lifetime
- 2000-12-12 ES ES00991169T patent/ES2240233T3/es not_active Expired - Lifetime
- 2000-12-12 KR KR1020027008155A patent/KR100768361B1/ko not_active Expired - Lifetime
- 2000-12-12 MX MXPA02006243A patent/MXPA02006243A/es active IP Right Grant
- 2000-12-12 CN CNB008189676A patent/CN1235890C/zh not_active Expired - Lifetime
- 2000-12-12 DE DE50010060T patent/DE50010060D1/de not_active Expired - Lifetime
- 2000-12-12 BR BRPI0017030A patent/BR0017030B8/pt not_active IP Right Cessation
- 2000-12-12 EP EP00991169A patent/EP1244641B1/de not_active Expired - Lifetime
- 2000-12-12 PL PL356484A patent/PL208707B1/pl unknown
- 2000-12-12 NZ NZ519701A patent/NZ519701A/en not_active IP Right Cessation
- 2000-12-12 DK DK00991169T patent/DK1244641T3/da active
- 2000-12-12 CA CA002396720A patent/CA2396720C/en not_active Expired - Lifetime
- 2000-12-12 PT PT00991169T patent/PT1244641E/pt unknown
- 2000-12-12 WO PCT/EP2000/012564 patent/WO2001047904A1/de not_active Ceased
- 2000-12-12 AU AU31574/01A patent/AU784286B2/en not_active Expired
- 2000-12-12 IL IL14989700A patent/IL149897A0/xx active IP Right Grant
- 2000-12-12 AT AT00991169T patent/ATE293104T1/de active
- 2000-12-20 AR ARP000106789A patent/AR029210A1/es active IP Right Grant
- 2000-12-20 UY UY26495A patent/UY26495A1/es not_active Application Discontinuation
- 2000-12-21 MY MYPI20006089A patent/MY134880A/en unknown
- 2000-12-22 CO CO00097414A patent/CO5261491A1/es active IP Right Grant
- 2000-12-22 TW TW089127599A patent/TWI256951B/zh not_active IP Right Cessation
- 2000-12-22 PE PE2000001387A patent/PE20010964A1/es not_active IP Right Cessation
- 2000-12-22 SV SV2000000249A patent/SV2002000249A/es active IP Right Grant
-
2002
- 2002-05-28 IL IL149897A patent/IL149897A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI256951B (en) | Thiazolyl amide derivatives | |
| ZA200201511B (en) | 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents. | |
| IL147925A0 (en) | 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents | |
| GB9911053D0 (en) | 4,5,6,7-tetrahydroindazole derivatives process for their preparation and their use as antitumour agents | |
| HUP0203766A3 (en) | 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them | |
| CA2400268A1 (en) | Pyrrolopyrimidinone derivatives, process of preparation and use | |
| HUP0203190A3 (en) | Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof | |
| IL153273A0 (en) | Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament | |
| MY134892A (en) | Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use | |
| IL185118A0 (en) | 5-membered heterocycle derivatives,production thereof and use thereof as medicaments | |
| AU2002213977A1 (en) | Novel anticholinergics, method for the production thereof and use thereof as medicaments | |
| HUP0400932A3 (en) | Pharmaceutical composition containing nateglinide and another antidiabetic compound, process for its preparation and for use the same | |
| CA2262566A1 (en) | Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect | |
| HUP0600854A2 (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same | |
| IL149400A0 (en) | Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments | |
| SI1268522T1 (sl) | Novi antagonisti lhrh, njihova priprava in uporaba kot zdravila | |
| IL159570A0 (en) | Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents | |
| HUP0300222A3 (en) | Novel lhrh-antagonists, production and use thereof as medicament | |
| EP1059304A4 (en) | NOVEL POLYSACCHARIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITIONS CONTAINING THESE NEW DERIVATIVES AS ACTIVE INGREDIENT | |
| IL148161A0 (en) | Process for the preparation of 2-cyanopyridines | |
| PL346015A1 (en) | Methoximinophenylacetic acid amides | |
| HUP0001249A3 (en) | Novel substituted dimeric compounds, process for their production and medicaments containing the same | |
| HUP0203593A3 (en) | Amycomycin, a process for its production and its use as a pharmaceutical | |
| TW334424B (en) | L-arginine aldehyde derivatives process for preparing them and pharmaceutical composition | |
| AU1022201A (en) | Novel LTB4 antagonist, method for the production thereof and its use as a medicament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4A | Expiration of patent term of an invention patent |